Epoch Investment Partners, Inc. Charles River Laboratories International, Inc. Transaction History
Epoch Investment Partners, Inc.
- $21.8 Billion
- Q1 2024
A detailed history of Epoch Investment Partners, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 247,501 shares of CRL stock, worth $51.6 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
247,501
Previous 8,735
2733.44%
Holding current value
$51.6 Million
Previous $2.06 Million
3149.03%
% of portfolio
0.31%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding CRL
# of Institutions
726Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.26 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.08 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$436 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$391 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$315 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.6B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...